The Evaluation of a Novel Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
1 other identifier
interventional
9
1 country
1
Brief Summary
This investigation is a prospective, non randomized, non blinded study. This investigation is designed to evaluate the performance, comfort and ease of use with the F\&P trial nasal pillows mask amongst Obstructive Sleep Apnea (OSA) participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2018
CompletedFirst Posted
Study publicly available on registry
July 30, 2018
CompletedStudy Start
First participant enrolled
August 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2018
CompletedAugust 15, 2018
July 1, 2018
3 days
July 22, 2018
August 13, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Ease of use
Subjective Questionnaire
1 night
Acceptability
Subjective Questionnaire
1 night
Secondary Outcomes (1)
Objective Leak Data
1 night
Study Arms (1)
Trial Continuous Positive Airway Pressure (CPAP) mask
EXPERIMENTALTrial nasal pillows CPAP mask
Interventions
Investigative Nasal pillows Mask to be used for OSA therapy
Eligibility Criteria
You may qualify if:
- Adult (18+ years of age)
- Able to give consent
- Apnea hypopnea Index (AHI)≥ 5 on diagnostic night
- Prescribed PAP for OSA
- Existing nasal pillows mask user
You may not qualify if:
- Inability to give consent
- Patients who are in a coma or a decreased level of consciousness
- Anatomical or physiological conditions making automatic positive airway pressure (APAP) therapy inappropriate (e.g. unconsolidated facial structure)
- Commercial drivers who are investigated by New Zealand Transport Agency
- Current diagnosis of carbon dioxide (CO2) retention
- Pregnant or may think they are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fisher & Paykel Helathcare
Auckland, New Zealand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bhavi Ogra
Employee
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2018
First Posted
July 30, 2018
Study Start
August 7, 2018
Primary Completion
August 10, 2018
Study Completion
August 10, 2018
Last Updated
August 15, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share